146 related articles for article (PubMed ID: 11330471)
1. Comparison of the reactivity of oxaliplatin, pt(diaminocyclohexane)Cl2 and pt(diaminocyclohexane1)(OH2)2(2+) with guanosine and L-methionine.
Verstraete S; Heudi O; Cailleux A; Allain P
J Inorg Biochem; 2001 Mar; 84(1-2):129-35. PubMed ID: 11330471
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of reaction of L-methionine with carboplatin and oxaliplatin in different media: a comparison with cisplatin.
Heudi O; Mercier-Jobard S; Cailleux A; Allain P
Biopharm Drug Dispos; 1999 Mar; 20(2):107-16. PubMed ID: 10206326
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin.
Screnci D; Er HM; Hambley TW; Galettis P; Brouwer W; McKeage MJ
Br J Cancer; 1997; 76(4):502-10. PubMed ID: 9275028
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells.
Luo FR; Wyrick SD; Chaney SG
Oncol Res; 1998; 10(11-12):595-603. PubMed ID: 10367941
[TBL] [Abstract][Full Text] [Related]
5. Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model.
Luo FR; Wyrick SD; Chaney SG
Cancer Chemother Pharmacol; 1999; 44(1):29-38. PubMed ID: 10367746
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity.
Shord SS; Bernard SA; Lindley C; Blodgett A; Mehta V; Churchel MA; Poole M; Pescatore SL; Luo FR; Chaney SG
Anticancer Res; 2002; 22(4):2301-9. PubMed ID: 12174918
[TBL] [Abstract][Full Text] [Related]
7. Biotransformations of oxaliplatin in rat blood in vitro.
Luo FR; Wyrick SD; Chaney SG
J Biochem Mol Toxicol; 1999; 13(3-4):159-69. PubMed ID: 10098901
[TBL] [Abstract][Full Text] [Related]
8. Application of capillary electrophoresis-mass spectrometry for the investigation of the binding behavior of oxaliplatin to 5'-GMP in the presence of the sulfur-containing amino acid L-methionine.
Strickmann DB; Kong A; Keppler BK
Electrophoresis; 2002 Jan; 23(1):74-80. PubMed ID: 11824623
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic and kinetic studies on reactions of Pt(II) complexes with biologically relevant nucleophiles.
Summa N; Schiessl W; Puchta R; van Eikema Hommes N; van Eldik R
Inorg Chem; 2006 Apr; 45(7):2948-59. PubMed ID: 16562950
[TBL] [Abstract][Full Text] [Related]
11. Biophysical analysis of DNA modified by 1,2-diaminocyclohexane platinum(II) complexes.
Boudný V; Vrána O; Gaucheron F; Kleinwachter V; Leng M; Brabec V
Nucleic Acids Res; 1992 Jan; 20(2):267-72. PubMed ID: 1741252
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats.
Luo FR; Wyrick SD; Chaney SG
Cancer Chemother Pharmacol; 1999; 44(1):19-28. PubMed ID: 10367745
[TBL] [Abstract][Full Text] [Related]
13. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
Pang SK; So WK; Ho YP; Au-Yeung CF
Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex.
Jerremalm E; Hedeland M; Wallin I; Bondesson U; Ehrsson H
Pharm Res; 2004 May; 21(5):891-4. PubMed ID: 15180350
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry.
Küng A; Strickmann DB; Galanski MS; Keppler BK
J Inorg Biochem; 2001 Oct; 86(4):691-8. PubMed ID: 11583787
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin.
Luo FR; Yen TY; Wyrick SD; Chaney SG
J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(2):345-56. PubMed ID: 10219677
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.
Pendyala L; Kidani Y; Perez R; Wilkes J; Bernacki RJ; Creaven PJ
Cancer Lett; 1995 Nov; 97(2):177-84. PubMed ID: 7497460
[TBL] [Abstract][Full Text] [Related]
18. The impact of different chelating leaving groups on the substitution kinetics of mononuclear Pt(II)(1,2-trans-R,R-diaminocyclohexane)(X-Y) complexes.
Summa N; Soldatović T; Dahlenburg L; Bugarcić ZD; van Eldik R
J Biol Inorg Chem; 2007 May; 12(4):461-75. PubMed ID: 17245597
[TBL] [Abstract][Full Text] [Related]
19. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
20. New Pt-NNSO core anticancer agents: Structural optimization and investigation of their anticancer activity.
Chong SX; Jin Y; Au-Yeung SC; To KK
J Inorg Biochem; 2017 May; 170():34-45. PubMed ID: 28214754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]